Literature DB >> 2859525

Absence of growth by most receptor-expressing fetal thymocytes in the presence of interleukin-2.

H von Boehmer, A Crisanti, P Kisielow, W Haas.   

Abstract

The growth of mature T cells is regulated by receptors for interleukin-2 (IL-2) and by IL-2 itself. Binding of antigen to T-cell antigen receptors induces the expression of IL-2 receptors, and binding of IL-2 to these receptors induces transferrin receptor expression and is sufficient to promote the growth of T cells for several days. However, nothing is known about the growth requirements of pre-T cells. We have therefore studied the dividing population of T-cell precursors which carry the Thy-1 surface antigen, but lack surface antigens Ly2 and L3T4; these cells are present in 14-day-old embryonic thymus. If the thymus is removed at this stage and placed in organ culture, all lymphocyte subpopulations normally present in thymuses of adult mice develop in vitro, that is, the nonfunctional Ly2+, L3T4+ population and the functional Ly2+, L3T4- and Ly2-, L3T4+ populations. We now report that, in contrast to their progeny, the early Ly2-, L3T4- cells express large amounts of IL-2 receptors, but most of them do not grow in IL-2-containing media outside the thymus. In contrast to dividing mature T cells, most fetal thymocytes express low amounts of transferrin receptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859525     DOI: 10.1038/314539a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  17 in total

1.  Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis.

Authors:  C F Moyer; J D Strandberg; C L Reinisch
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

2.  A role for T3+4-6-8- transitional thymocytes in the differentiation of mature and functional T cells from human prothymocytes.

Authors:  M L Toribio; C Martinez; M A Marcos; C Marquez; E Cabrero; A de la Hera
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Early precursor thymocytes can produce interleukin 2 upon stimulation with calcium ionophore and phorbol ester.

Authors:  J P Lugo; S N Krishnan; R D Sailor; E V Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

Review 4.  In vivo proliferation and differentiation of prothymocytes in the thymus.

Authors:  C Penit
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

5.  The Pgp-1 antigen is expressed on early fetal thymocytes.

Authors:  J Lesley; J Trotter; R Hyman
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

6.  Expression of p75 chain of IL-2 receptor in the early immunological reconstitution after allogeneic bone marrow transplantation.

Authors:  P Comoli; R Maccario; D Montagna; M Labirio; M Zecca; R Clementi; F Bonetti; F Locatelli
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

7.  Phenotypic and functional analysis of positive selection in the gamma/delta T cell lineage.

Authors:  F B Wells; Y Tatsumi; J A Bluestone; S M Hedrick; J P Allison; L A Matis
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

8.  Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells.

Authors:  J P DiSanto; F Rieux-Laucat; A Dautry-Varsat; A Fischer; G de Saint Basile
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

9.  Developmental control of lymphokine gene expression in fetal thymocytes during T-cell ontogeny.

Authors:  S R Carding; E J Jenkinson; R Kingston; A C Hayday; K Bottomly; J J Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

10.  A murine early thymocyte developmental sequence is marked by transient expression of the interleukin 2 receptor.

Authors:  M Pearse; L Wu; M Egerton; A Wilson; K Shortman; R Scollay
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.